As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

11/30/23  Acer Therapeutics Inc.            15-12G     11/30/23    1:12K                                    Donnelley … Solutions/FA 
11/24/23‡ Acer Therapeutics Inc.            EFFECT     11/24/23    1:2K                                     SEC #5                   
11/24/23‡ Acer Therapeutics Inc.            EFFECT     11/24/23    1:2K                                     SEC #5                   
11/20/23  Aselage Steve                     4          Director²   1:6K   Acer Therapeutics Inc.            Donnelley Fin’l S… 06/FA 
11/20/23  Dunn John Michael                 4          Director²   1:6K   Acer Therapeutics Inc.            Donnelley Fin’l S… 06/FA 
11/20/23  Joseph Donald                     4          Officer²    1:6K   Acer Therapeutics Inc.            Donnelley Fin’l S… 06/FA 
11/20/23  Schelling Chris                   4          D,O,%Owner² 1:6K   Acer Therapeutics Inc.            Donnelley Fin’l S… 06/FA 
11/20/23  Palmin Harry S                    4          Officer²    1:6K   Acer Therapeutics Inc.            Donnelley Fin’l S… 06/FA 
11/20/23  Davis Jefferson E                 4          Officer²    1:6K   Acer Therapeutics Inc.            Donnelley Fin’l S… 06/FA 
11/20/23  Acer Therapeutics Inc.            10-Q        9/30/23   70:10M                                    Donnelley … Solutions/FA 
11/20/23  Acer Therapeutics Inc.            S-8 POS    11/20/23    1:34K                                    Donnelley … Solutions/FA 
11/20/23  Acer Therapeutics Inc.            S-8 POS    11/20/23    1:34K                                    Donnelley … Solutions/FA 
11/20/23  Acer Therapeutics Inc.            S-8 POS    11/20/23    1:34K                                    Donnelley … Solutions/FA 
11/20/23  Acer Therapeutics Inc.            S-8 POS    11/20/23    1:34K                                    Donnelley … Solutions/FA 
11/20/23  Acer Therapeutics Inc.            S-8 POS    11/20/23    1:34K                                    Donnelley … Solutions/FA 
11/20/23  Acer Therapeutics Inc.            S-8 POS    11/20/23    1:34K                                    Donnelley … Solutions/FA 
11/20/23  Acer Therapeutics Inc.            S-8 POS    11/20/23    1:34K                                    Donnelley … Solutions/FA 
11/20/23  Acer Therapeutics Inc.            S-8 POS    11/20/23    1:34K                                    Donnelley … Solutions/FA 
11/20/23  Acer Therapeutics Inc.            S-8 POS    11/20/23    1:34K                                    Donnelley … Solutions/FA 
11/20/23  Acer Therapeutics Inc.            S-8 POS    11/20/23    1:34K                                    Donnelley … Solutions/FA 

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:  -K
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	10-Q	Quarterly Report — Form 10-Q.
	15-12G	Certification of a Termination of Registration of a Class of Securities — Form 15.
	EFFECT	SEC Notice of Effectiveness.
	S-8 POS	Post-Effective Amendment of a Form S-8 Registration.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.